LEO Pharma A/S v. Tolmar Inc.
1:10-cv-00269
Overview
Parties
Defendant
Tolmar Inc. Operating Company
Represented By
11 Attorneys ListedYoung, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Young, Conaway, Stargatt & Taylor LLP
Rodney Square, 1000 North King Street
Teva Pharmaceuticals Industries Ltd. Operating Company
Represented By
1 Attorneys ListedPhillips, McLaughlin & Hall, P.A.
Phillips, McLaughlin & Hall, P.A., 1200 N. Broom St
Plaintiff
LEO Pharma A/S NPE (Individual / Inventor)
Represented By
3 Attorneys ListedMorris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Morris, Nichols, Arsht & Tunnell LLP
1201 North Market Street, P.O. Box 1347
Special Master
Richard K. Herrmann, -SM- Operating Company
Represented By
0 Attorneys ListedCourt & Judges
Court
District Court, D. Delaware (ded)
Presiding Judge
Global Patent Family Cross-Litigation Radar
CasLoc 360° Radar 4 Family MembersMulti-jurisdiction dispute tracking across USPTO PTAB, U.S. Federal Courts, Unified Patent Court (UPC), and EPO Oppositions
| Jurisdiction | Publication Number | Relationship | Official Record |
|---|---|---|---|
| 🇺🇸 United States | US 5,763,426 Asserted | Asserted Patent | View Official Patent → |
| 🇬🇧 United Kingdom | GB 939300763 A | United Kingdom Counterpart | View Official Patent → |
| 🇬🇧 United Kingdom | GB 9300763 D0 | United Kingdom Counterpart | View Official Patent → |
| 🌐 PCT International (WIPO) | WO 1994015912 A1 | PCT World Application | View Official Patent → |
No active co-pending lawsuits found across other jurisdictions for this family. All related sibling filings are currently unlitigated.
Patents Involved
There are 3 patents involved in this case.
| Patent Asset | Filing & Issue Date | Expiration & Term Status | External Links |
|---|---|---|---|
|
US5763426
Crystalline form of a vitamin D analogue
|
Filed: 1993-01-15
Issued: 1998-06-09
|
Expired (Term Ended)
Expires: 2013-01-15
|
|
|
USRE39706
Crystalline form of a vitamin D analogue
|
Filed: 1993-01-15
Issued: 2007-06-26
|
Expired (Term Ended)
Expires: 2013-01-15
|
|
|
US6753013
Pharmaceutical composition
|
Filed: 2000-01-27
Issued: 2004-06-22
|
Expired (Term Ended)
Expires: 2020-01-27
|
Patent Enforceability & Injunction Risk Assessment
Statutorily Barred — Patent expired. Under 35 U.S.C. § 283, courts cannot grant an injunction once a patent's term concludes. Litigation is restricted exclusively to past damages lookback.
Standard Statutory Term — No obviousness-type double patenting truncation noted.
Under 35 U.S.C. § 286, damages cannot accrue for infringement prior to 6 years before filing. 4th & 8th Year Maintenance Fees Paid (12th Year Window Upcoming).
Procedural Motions & Interlocutory Orders
Total Motions
27
Dispositive
0
Granted
0
Denied
2
Pending / Review
22
Motions by Category
Key Dispositive Motions & Rulings